Environmental, Social And Governance Report

Overview

The report describes Kelun Pharma's 2024 ESG governance and performance across its group and subsidiaries. It highlights 21,864 employees, a three-tier ESG governance structure with the Board of Directors holding ultimate responsibility, and extensive healthcare-access, product-quality, employee, and supply-chain initiatives. Climate disclosures report total GHG emissions of 2,845,549.25 tCO2e, including Scope 1 and Scope 2 figures, while environmental management covers energy, water, waste, biodiversity, and low-carbon measures.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services